Analysis of HIV-1 clinical trials: statistical magic?

There are now many different combination regimens available for the treatment of HIV-1 infection. Undetectability of HIV-1 RNA is discussed.

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 353; no. 9169; pp. 2061 - 2064
Main Author The AVANTI Steering Committee
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 12.06.1999
Lancet
Elsevier Limited
Subjects
Biological and medical sciences
Clinical trial. Drug monitoring
Drug therapy
General pharmacology
HIV
Human immunodeficiency virus
Human viral diseases
Infectious diseases
Medical diagnosis
Medical sciences
Pharmacology. Drug treatments
Ribonucleic acid
RNA
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Human
Immunopathology
Evaluation
State of the art
Statistical analysis
HIV-1 virus
Treatment efficiency
Retroviridae
AIDS
Immune deficiency
Lentivirus
Infection
Virus
Viral disease
Antiviral
Clinical trial
Human immunodeficiency virus
Online AccessGet full text

Cover

More Information
Summary:There are now many different combination regimens available for the treatment of HIV-1 infection. Undetectability of HIV-1 RNA is discussed.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(98)10391-4